Latest Commercial Contracts News

Urbanise.com Limited appoints Darc Rasmussen as Executive Chairman, unveils an AI Assistant for strata managers, and converts two legacy system customers with new contracts worth $700k over three years.

Papyrus Australia has fulfilled a critical contract milestone by delivering 200 biodegradable Collar Keeper product samples to TBS Mining Solutions, enabling the next phase of product testing despite a slight delay.

ClearVue Technologies has secured a A$305,000 contract to supply over 800m² of building-integrated photovoltaic glazing for the Rio Business Centre redevelopment in Paphos, Cyprus, marking a tangible commercial step for its solar façade technology.

Mach7 Technologies has secured a five-year, A$1.7 million subscription contract with US teleradiology provider AMRADNET, slashing deployment time from 12 months to just 45 days.

ClearVue Technologies has secured TÜV SÜD certification for its Thermal Management Junction Box, validating its safety and durability for global BIPV deployment.

Archer Materials is progressing toward demonstrating a working qubit this year while scaling quantum device fabrication from lab prototypes to wafer-scale manufacturing using semiconductor industry standards.

SKS Technologies has landed a $22 million contract to deliver integrated electrical systems for a major retailer's new Melbourne headquarters, pushing its order book to $355 million amid a booming project pipeline.

InteliCare has secured A$2.05 million through a placement to back its commercial expansion following major aged care contracts and initial retirement village deployments.

NH3 Clean Energy’s WAH2 Clean Ammonia Project has been granted Federal Major Project Status, accelerating government approvals and supporting a Final Investment Decision by end 2026.

Ava Risk Group posted a $6.1 million Q3 sales intake and secured a $7 million strategic investment to fuel US expansion, while geopolitical tensions delay some Middle East orders.

4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.

Delorean Corporation reported solid progress in Q3 FY2026, including a positive Final Investment Decision for its NSW1 Horsley Park bioenergy facility backed by $30.5 million in grants, alongside ongoing construction at its flagship SA1 Salisbury project.